Outcomes4Me Secures $21M in Funding Learn more >>

Patient Login
Patient Sign Up
Log out
Go to Patient Dashboard
Go to Dashboard
Patient Login
Patient Sign Up
Log out
Go to Patient Dashboard
Go to Dashboard

Learn | Resources to take control of your cancer

Explore articles on personalized treatment options, clinical trials,
and symptom management to empower every step of your journey.
DNA test concept, genetic profiling background

ASCO 2025: Enhertu remains efficacious regardless of mutation status in HER2-low, ultra-low metastatic breast cancer

Enhertu (fam-trastuzumab deruxtecan-nxki or T-DXd) has shown promising results in slowing down or stopping the...
older woman looking at tablet at home

ASCO 2025: A glimpse into the future of breast cancer care

The American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30...
A scientist placing a slide under a microscope close up

ASCO 2025: Re-evaluating HER2 levels in ER-positive breast cancer

A recent study is aiming to understand and classify the HER2 protein levels in breast...
doctor researchers working together in medical lab

ASCO 2025: Using artificial intelligence in HER2-low breast cancer pathology

One of the most important first steps after receiving a breast cancer diagnosis is understanding...